Skip to main content
Insights into Imaging
Fig. 2 | Insights into Imaging

Fig. 2

From: AI analytics can be used as imaging biomarkers for predicting invasive upgrade of ductal carcinoma in situ

Fig. 2

A 49-year-old female patient with pure ductal carcinoma in situ. The patient was referred to our hospital due to a screening-detected calcification in the left lower medial breast. The calcification was assessed as BI-RADS category 4B by the breast radiologist (A) and the AI-CAD score was 42% (B). A stereotactic biopsy was performed, confirming ductal carcinoma in situ. Following partial mastectomy, the final pathology revealed pure ductal carcinoma in situ with intermediate nuclear grade and the presence of comedo necrosis

Back to article page